Massimo Gentile
Impact in
- Genetics top 0.2%
- Chronic Lymphocytic Leukemia Research
- Hematology top 0.5%
- Multiple Myeloma Research and Treatments
- Chronic Myeloid Leukemia Treatments
Papers in
- Genetics 210
- Chronic Lymphocytic Leukemia Research 193
- Hematology 127
- Multiple Myeloma Research and Treatments 76
- Chronic Myeloid Leukemia Treatments 22
- Acute Myeloid Leukemia Research 19
- Co-authors
- Fortunato Morabito (142 shared papers)Antonino Neri (70 shared papers)Ernesto Vigna (81 shared papers)Anna Grazia Recchia (50 shared papers)Giovanna Cutrona (36 shared papers)Manlio Ferrarini (33 shared papers)Stefano Molica (31 shared papers)Francesca Romana Mauro (21 shared papers)
- Journals
- European Journal Of Haematology (37 papers)Blood (30 papers)American Journal of Hematology (26 papers)Hematological Oncology (25 papers)Leukemia (15 papers)
- Partner nations
- ItalyUnited StatesSpain
In The Last Decade
Massimo Gentile
320 papers receiving 5.6k citations
Massimo Gentile's Hit Papers
Peers
Comparison fields: 5 of 108
- Genetics 2.8k
- Hematology 1.6k
- Pathology and Forensic Medicine 1.7k
- Oncology 1.6k
- Immunology 1.3k
Countries citing papers authored by Massimo Gentile
This map shows the geographic impact of Massimo Gentile's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Massimo Gentile with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Massimo Gentile more than expected).
Fields of papers citing papers by Massimo Gentile
This network shows the impact of papers produced by Massimo Gentile. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Massimo Gentile. The network helps show where Massimo Gentile may publish in the future.
Co-authors
The 25 scholars most cited alongside Massimo Gentile, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 353 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Clinical characteristics and risk factors associated with COVID-19 severity in patients with haematological malignancies in Italy: a retrospective, multicentre, cohort study Hit paper breakdown → | 2020 | 427 |
| 2 | 2020 | 216 | |
| 3 | 2015 | 187 | |
| 4 | 2020 | 100 | |
| 5 | 2013 | 76 | |
| 6 | 2021 | 75 | |
| 7 | 2003 | 74 | |
| 8 | 2020 | 71 | |
| 9 | 2009 | 70 | |
| 10 | 2020 | 67 | |
| 11 | 2022 | 67 | |
| 12 | 2016 | 63 | |
| 13 | 2018 | 60 | |
| 14 | 2013 | 58 | |
| 15 | 2011 | 57 | |
| 16 | 2015 | 57 | |
| 17 | 2015 | 55 | |
| 18 | 2008 | 54 | |
| 19 | 2014 | 54 | |
| 20 | 2014 | 54 |
About Massimo Gentile
Massimo Gentile is a scholar working on Genetics, Hematology, Pathology and Forensic Medicine, Immunology and Oncology, having authored 353 papers that have together received 5.7k indexed citations. Recurring topics across this work include Chronic Lymphocytic Leukemia Research (193 papers), Lymphoma Diagnosis and Treatment (114 papers), Multiple Myeloma Research and Treatments (76 papers), Immunodeficiency and Autoimmune Disorders (54 papers), Protein Degradation and Inhibitors (35 papers), Peptidase Inhibition and Analysis (25 papers), Chronic Myeloid Leukemia Treatments (22 papers) and Acute Myeloid Leukemia Research (19 papers). The work is most often cited by research in Genetics (2.8k citations), Hematology (1.6k citations), Pathology and Forensic Medicine (1.7k citations), Oncology (1.6k citations) and Immunology (1.3k citations). Massimo Gentile has collaborated with scholars based in Italy, United States and Spain. Frequent co-authors include Fortunato Morabito, Antonino Neri, Ernesto Vigna, Anna Grazia Recchia, Giovanna Cutrona, Manlio Ferrarini, Stefano Molica, Francesca Romana Mauro, Diana Giannarelli and Serena Matis. Their work appears in journals such as European Journal Of Haematology, Blood, American Journal of Hematology, Hematological Oncology and Leukemia.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.